{"id":815390,"date":"2025-02-20T07:03:19","date_gmt":"2025-02-20T12:03:19","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-6-2025\/"},"modified":"2025-02-20T07:03:19","modified_gmt":"2025-02-20T12:03:19","slug":"mindmed-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-6-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-6-2025\/","title":{"rendered":"MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on <\/b><b>March 6, 2025<\/b><\/p>\n<p>NEW YORK&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nMind Medicine (MindMed) Inc. (Nasdaq: MNMD), (the &#8220;Company&#8221; or &#8220;MindMed&#8221;), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that it will host a live webcast at 8:00 a.m. ET on Thursday, March 6, 2025 to report financial results for the fourth quarter and year ended December 31, 2024, and discuss recent business updates.\n<\/p>\n<p>\nListeners can register for the webcast via this <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fedge.media-server.com%2Fmmc%2Fp%2Fhvaakjti&amp;esheet=54210017&amp;newsitemid=20250220848926&amp;lan=en-US&amp;anchor=link&amp;index=1&amp;md5=76880a75f59804d6566b95ec76c61fcf\">link<\/a>. Analysts wishing to participate in the question and answer session should use this <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fregister.vevent.com%2Fregister%2FBI1aa1f50343ca4ea1a90990ca8adfd0dc&amp;esheet=54210017&amp;newsitemid=20250220848926&amp;lan=en-US&amp;anchor=link&amp;index=2&amp;md5=6803027ce52dd365c473c311ee63a838\">link<\/a>. A replay of the webcast will be available via the Investor Relations section of the MindMed website, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fir.mindmed.co%2Fnews-events%2Fir-calendar&amp;esheet=54210017&amp;newsitemid=20250220848926&amp;lan=en-US&amp;anchor=ir.mindmed.co&amp;index=3&amp;md5=1b4c17794dffc06e0a6c1e6a22b0c840\">ir.mindmed.co<\/a>, and archived for at least 30 days after the webcast. Those who plan on participating are advised to join 15 minutes prior to the start time.\n<\/p>\n<p><b>About MindMed<\/b><\/p>\n<p>\nMindMed is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways that play key roles in brain health. MindMed trades on Nasdaq under the symbol MNMD.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250220848926r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20250220848926\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20250220848926\/en\/<\/a><\/span><\/p>\n<p><b>For Media:<\/b><a rel=\"nofollow\" href=\"mailto:media@mindmed.co\">media@mindmed.co<br \/>\n<\/a><br \/><b>For Investors:<\/b><a rel=\"nofollow\" href=\"mailto:ir@mindmed.co\">ir@mindmed.co<\/a><\/p>\n<p><b>KEYWORDS:<\/b> United States North America Canada New York<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Mental Health Health Neurology Other Health Pharmaceutical Biotechnology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250220848926\/en\/2047733\/3\/MNMD_Logo.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025 NEW YORK&#8211;(BUSINESS WIRE)&#8211; Mind Medicine (MindMed) Inc. (Nasdaq: MNMD), (the &#8220;Company&#8221; or &#8220;MindMed&#8221;), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that it will host a live webcast at 8:00 a.m. ET on Thursday, March 6, 2025 to report financial results for the fourth quarter and year ended December 31, 2024, and discuss recent business updates. Listeners can register for the webcast via this link. Analysts wishing to participate in the question and answer session should use this link. A replay of the webcast will be available via the Investor Relations section of the MindMed website, ir.mindmed.co, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-6-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-815390","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-6-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025 NEW YORK&#8211;(BUSINESS WIRE)&#8211; Mind Medicine (MindMed) Inc. (Nasdaq: MNMD), (the &#8220;Company&#8221; or &#8220;MindMed&#8221;), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that it will host a live webcast at 8:00 a.m. ET on Thursday, March 6, 2025 to report financial results for the fourth quarter and year ended December 31, 2024, and discuss recent business updates. Listeners can register for the webcast via this link. Analysts wishing to participate in the question and answer session should use this link. A replay of the webcast will be available via the Investor Relations section of the MindMed website, ir.mindmed.co, &hellip; Continue reading &quot;MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-6-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-20T12:03:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250220848926r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mindmed-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-6-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mindmed-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-6-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025\",\"datePublished\":\"2025-02-20T12:03:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mindmed-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-6-2025\\\/\"},\"wordCount\":270,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mindmed-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-6-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250220848926r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mindmed-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-6-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mindmed-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-6-2025\\\/\",\"name\":\"MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mindmed-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-6-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mindmed-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-6-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250220848926r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2025-02-20T12:03:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mindmed-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-6-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mindmed-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-6-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mindmed-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-6-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250220848926r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250220848926r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mindmed-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-6-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-6-2025\/","og_locale":"en_US","og_type":"article","og_title":"MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025 - Market Newsdesk","og_description":"MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025 NEW YORK&#8211;(BUSINESS WIRE)&#8211; Mind Medicine (MindMed) Inc. (Nasdaq: MNMD), (the &#8220;Company&#8221; or &#8220;MindMed&#8221;), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that it will host a live webcast at 8:00 a.m. ET on Thursday, March 6, 2025 to report financial results for the fourth quarter and year ended December 31, 2024, and discuss recent business updates. Listeners can register for the webcast via this link. Analysts wishing to participate in the question and answer session should use this link. A replay of the webcast will be available via the Investor Relations section of the MindMed website, ir.mindmed.co, &hellip; Continue reading \"MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-6-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-20T12:03:19+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250220848926r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-6-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-6-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025","datePublished":"2025-02-20T12:03:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-6-2025\/"},"wordCount":270,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-6-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250220848926r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-6-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-6-2025\/","name":"MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-6-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-6-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250220848926r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2025-02-20T12:03:19+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-6-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-6-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-6-2025\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250220848926r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250220848926r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mindmed-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-6-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/815390","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=815390"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/815390\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=815390"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=815390"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=815390"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}